United Therapeutics
Clinical trials sponsored by United Therapeutics, explained in plain language.
Develops therapies for pulmonary arterial hypertension and other chronic diseases.
Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
Advertising disclosure. Links marked "(ad)" go to partners we have a commercial relationship with, either a broker where you can trade or a stock-research service, and we may earn a commission if you open an account or subscribe. This never affects what is shown here.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New hope for PAH patients: Long-Term drug safety trial opens Results expected Dec 2026 (estimated) May already have reported ↗
- New registry follows PAH patients on orenitram in Real-World settings Results expected Mar 2027 (estimated)
-
Pig kidney trial offers hope to thousands waiting for transplants
Disease control Recruiting nowThis study is testing whether a kidney from a genetically modified pig can safely work in people with end-stage renal disease who cannot get a human kidney. Up to 50 participants will receive the pig kidney and be followed for at least 24 weeks to check survival, kidney function,…
Phase 1/2 • Sponsor: United Therapeutics • Aim: Disease control
Last updated Sep 11, 2026 00:00 UTC
-
Inhaled treprostinil aims to slow lung decline in fibrosis trial
Disease control Recruiting nowThis phase 3 study tests whether an inhaled drug called treprostinil can slow the worsening of lung function in people with progressive pulmonary fibrosis, a condition where lung scarring gets worse over time. About 698 adults will receive either the drug or a placebo four times …
Phase 3 • Sponsor: United Therapeutics • Aim: Disease control
Last updated Jul 15, 2026 00:00 UTC
-
Pig kidney transplant trial offers new hope for kidney patients
Disease control Recruiting nowThis study tests a genetically modified pig kidney (called the 10 GE Xenokidney) in 50 adults with end-stage kidney disease who cannot get a human kidney transplant or face a long wait. The goal is to see if the pig kidney works safely and well, improving survival and quality of …
Phase 1/2 • Sponsor: United Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC
-
New study to track lung and heart health in 900 patients
Knowledge-focused Recruiting nowThis study is a registry that will follow about 900 adults with both interstitial lung disease and pulmonary hypertension. Researchers will collect information on patients' medical history and track changes in their condition over time. The goal is to better understand these dise…
Sponsor: United Therapeutics • Aim: Knowledge-focused
Last updated Aug 28, 2026 00:00 UTC